Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells()()

Non–small cell lung carcinoma (NSCLC) is the most common cause of cancer deaths, with platin-based combination chemotherapy the most efficacious therapies. Gains in overall survival are modest, highlighting the need for novel therapeutic approaches including the development of next-generation platin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neoplasia
Egile Nagusiak: Bar, Jair, Hasim, Mohamed S., Baghai, Tabassom, Niknejad, Nima, Perkins, Theodore J., Stewart, David J., Sekhon, Harmanjatinder S., Villeneuve, Patrick J., Dimitroulakos, Jim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2016
Gaiak:
Original article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031866/
https://ncbi.nlm.nih.gov/pubmed/27659012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.07.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak